SCHEMBL7047571

SCHEMBL7047571

FC(F)(F)c1cccc(N2CCN(CCCSc3ccccn3)CC2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 9/20 0.64
DRD3 P35462 9/20 0.64
ADRA1A P35348 5/20 0.64
SIGMAR1 Q99720 2/20 0.61
HTR7 P34969 3/20 0.55
HRH4 Q9H3N8 1/20 0.54
DRD5 P21918 3/20 0.53
ALDH1A1 P00352 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
MAPT P10636 1/20 0.53
TSHR P16473 1/20 0.53
NFKB1 P19838 1/20 0.53
MAPK1 P28482 1/20 0.53
CYP2C19 P33261 1/20 0.53
THPO P40225 1/20 0.53
MTOR P42345 1/20 0.53
BLM P54132 1/20 0.53
PMP22 Q01453 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7047855 0.96 DRD2 (0.64) DRD2DRD3ADRA1ASIGMAR1HTR7
SCHEMBL8141289 0.88 DRD2 (0.61) DRD2DRD3ADRA1ASIGMAR1HTR7
SCHEMBL7455896 0.88 SIGMAR1 (0.56) DRD2DRD3ADRA1ASIGMAR1HTR7
SCHEMBL7674560 0.84 DRD2 (0.62) DRD2DRD3ADRA1ASIGMAR1HTR7
SCHEMBL12468732 0.81 DRD2 (0.54) DRD2DRD3ADRA1ASIGMAR1HTR7
SCHEMBL11465528 0.80 SIGMAR1 (0.76) DRD2DRD3ADRA1ASIGMAR1HTR7
SCHEMBL4608279 0.80 DRD2 (0.53) DRD2DRD3ADRA1ASIGMAR1HTR7
SCHEMBL8141285 0.79 DRD2 (0.49) DRD2DRD3ADRA1AHTR7DRD5
SCHEMBL21511115 0.78 KCNH2 (0.54) DRD2DRD3ADRA1ASIGMAR1HTR7
SCHEMBL1253143 0.78 SIGMAR1 (0.69) DRD2DRD3ADRA1ASIGMAR1HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0771197-B1 USE OF HETEROCYCLIC COMPOUNDS AS DOPAMINES-D 3- LIGANDS BASF AG (DE) 2003-04-09 EP disclosed
US-6090807-A Use of heterocyclic compounds BASF AKTIENGESELLSCHAFT (DE) 2000-07-18 US disclosed